AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2017
Oct 5, 2017
35081_dirs_2017-10-05_c383c421-be06-4b5d-a3b4-29d8b15b2ed1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2017-10-03
Reporting Person: Allen Richard T (Vice President of Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-10-03 | Common Stock | M | 585875 | $0.15 | Acquired | 585875 | Direct |
| 2017-10-03 | Common Stock | M | 237250 | $0.15 | Acquired | 823125 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-03 | Employee Stock Option (Right to Buy) | $0.15 | M | 585875 | Disposed | 2026-08-09 | Common Stock (585875) | Direct |
| 2017-10-03 | Employee Stock Option (Right to Buy) | $0.15 | M | 237250 | Disposed | 2026-08-19 | Common Stock (237250) | Direct |
Footnotes
F1: One-fourth of the shares subject to the option vest on December 1, 2016 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2: One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
More from BioCardia, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27